Issue of Equity

RNS Number : 4203T
Zoetic International PLC
14 November 2019
 

 

14 November 2019

 

Zoetic International plc

("Zoetic International" or the "Company")

 

Issue of shares

 

Zoetic International, the London listed vertically integrated CBD and natural resources company, announces that, pursuant to the exercise of warrants, an application has been made for an additional 200,000 ordinary shares in the Company ("New Ordinary Shares") to be admitted to trading on the Official List of the UK Listing Authority by way of a Standard Listing and to trading on the London Stock Exchange's Main Market for listed securities ("Admission"). Admission is expected to take place on 20 November 2019.

 

Following Admission, the New Ordinary Shares will rank pari passu in all respects with the existing ordinary shares of 1 pence each in issue, including the right to receive all dividends and other distributions declared, and the total number of ordinary shares in Zoetic International with voting rights will be 149,110,034. This figure may be used by Zoetic International shareholders as the denominator for calculations to determine if they have a notifiable interest in Zoetic International under the Disclosure and Transparency Rules, or if such interest has changed.

 

**ENDS**

 

Enquiries

 

Zoetic International plc                                                                                               +44 (0) 1738 472 029

Nick Tulloch

 

IFC Advisory Ltd                                                                                                              +44 (0) 20 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

               

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEKZLBFKFFFFBV
UK 100

Latest directors dealings